AR and prostate cancer: In line with this hypothesis, androgen receptor (AR) activation was shown to induce p53-independent senescence in prostate cancer cells (64, 65), and a short-term testosterone treatment was sufficient to induce SA-βGal activity in female Znrf3 cKO adrenals (Fig. 6).